This post was just published on ZYX Buy Change Alert. A quick denial of a potential deal is not typical, as has happened in the case of FLXN. One hypothetical explanation is that the deal is potentially in the works but a quick run-up in the stock makes the deal difficult. Hypothetically,
This post was just published on ZYX Buy Change Alert. You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES. Please click here to take advantage of a FREE 30 day trial. Check out our enviable performance
This post was just published on ZYX Buy Change Alert. More later You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES. Please click here to take advantage of a FREE 30 day trial. Check out our enviable
This post was just published on ZYX Buy Change Alert. The stock has surged to over $26 as of this writing. Consider not chasing the price. If you do not have a fill, we are raising the top end of the buy zone to $24.31 and the preferred point is being raised
This post was just published on ZYX Buy Change Alert. For us to recommend, a stock must pass at least four of the six screens. We prefer a stock to meet all six screens. Our rigorous criteria has led to enviable performance over a long period of time. We periodically provide intelligence
The real reason behind gold move is not what you think. It is the healthcare bill as I will explain later in this article. I will also show you how at The Arora Report we are extracting profits trade after trade from precious metals with a real live example of
This post was just published on ZYX Buy Change Alert. AMAT makes semiconductor manufacturing equipment. This has been one of the strongest stocks in Trump rally. AMAT is also in the Model Portfolio. Depending upon when and how you bought AMAT, you are looking at 79% to 150% return in about a
I’m constantly exposed to speculative biotechnology companies with promising treatments. But few pass our investing screens. Advanced Accelerator Applications SA AAAP, a 15-year-old French radiopharmaceutical company, has been getting a lot of publicity. The company claims to be close to bringing to market a therapy that targets the cancer that
This post was just published on ZYX Buy Change Alert. MU is long from $21.77. As of this writing it is trading at $25.83. Those holding more than 25% may consider taking partial profits right here. The reason is that Samsung is ramping up DRAM production. DRAMs are the primary source of
Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the